Publications and communications of Mégane Jassin

Bocuzzi, V., Marcion, G., Withofs, N., Hustinx, R., D'Huyvetter, M., Navarro, L., Dumoulin, M., Jassin, M., Caers, J., & Bridoux, J. (11 March 2025). Development of a Single-Domain Antibody-Based Radiopharmaceutical for Targeted Alpha Therapy of Multiple Myeloma [Poster presentation]. European Molecular Imaging Meeting (EMIM), Bilbao, Spain.

Bocuzzi, V., Marcion, G., Withofs, N., Hustinx, R., D'Huyvetter, M., Navarro, L., Dumoulin, M., Jassin, M., Caers, J., & Bridoux, J. (29 January 2025). CD38-based Targeted Alpha Therapy for the treatment of multiple myeloma [Poster presentation]. Seminaire Télévie, 4000 - Liège, Belgium.

Jassin, M., Onkelinx, C., E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., & Nguyen, T. T. (29 January 2025). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. Séminaire Télévie 2025, Liège, Belgium.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Charles, S., Dubois, S., Baron, F., & Ehx, G. (2025). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Poster presentation]. EACR Conference Persister Cells: from Bacteria to Cancer.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance. European Journal of Immunology. doi:10.1002/eji.202470200

E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Paper presentation]. EDT-Immunology PhD Day.

Jassin, M., Chloé Onkelinx, E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., & Nguyen, T. T. (15 February 2024). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. EBMT - EHA 6th European CAR T-cell Meeting, Valence, Spain.

Faville, C.* , E Silva, B.* , Jassin, M., DUBOIS, S., Daulne, C., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M.* , & Ehx, G.*. (06 February 2024). Discovery And Targeting of Persister-specific Antigens in Acute Myeloid Leukemia [Poster presentation]. Télévie Seminar.
* These authors have contributed equally to this work.

Faville, C.* , E Silva, B.* , Jassin, M., DUBOIS, S., Daulne, C., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M.* , & Ehx, G.*. (06 February 2024). Discovery And Targeting of Persister-specific Antigens in Acute Myeloid Leukemia [Paper presentation]. Télévie Seminar.
* These authors have contributed equally to this work.

Jassin, M., Chloé Onkelinx, E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., & Nguyen, T. T. (06 February 2024). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. Séminaire Télévie 2024.

Onkelinx, C., & Jassin, M. (05 February 2024). Caractérisation et comparaison entre un CAR-T standard et d'un nanoCAR-T ciblant BCMA dans le myélome multiple [Poster presentation]. Mémoire HEPL.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Poster presentation]. yBIS First Annual Meeting.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Poster presentation]. GIGA Day 2024.

E Silva, B., Faville, C., Jassin, M., DUBOIS, S., De Voeght, A., Baron, F., & Ehx, G. (09 September 2023). Characterizing the immune recognition of chemo-persister blasts in acute myeloid leukemia [Poster presentation]. GIGA Day 2023.

Jassin, M. (09 February 2023). Evaluation of new immunotherapeutic targets for multiple myeloma [Poster presentation]. 5th European CAR T-cell Meeting, Rotterdam, Netherlands.

Lejeune, M., Köse, M. C., Jassin, M., Gou, M.-J., Herbet, A., Duray, E., Cobraiville, G., FOGUENNE, J., Boquet, D., Gothot, A., Beguin, Y., Fillet, M., & Caers, J. (2023). Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma. HemaSphere, 22, 901. doi:10.1097/HS9.0000000000000901

Lebrun, M., Lambert, J., Zhou, M., Jassin, M., Oliver, S., Arvin, A., & Sadzot, C. (August 2021). The role of ORF9p in VZV-induced cell-cell fusion [Paper presentation]. 45th annual International Herpesvirus Workshop.